obesity

Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts
Fierce Pharma
Thu, 04/17/25 - 11:06 pm
diabetes
obesity
Eli Lilly
Novo Nordisk
BMO Capital Markets
Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s
Yahoo/Bloomberg
Thu, 04/17/25 - 11:34 am
Eli Lilly
clinical trials
obesity
orforglipron
Ozempic
Why Pfizer Stock Topped the Market on Tuesday
Motley Fool
Tue, 04/15/25 - 07:53 pm
Pfizer
PF-07976016
obesity
clinical trials
Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan
Fierce Biotech
Mon, 04/14/25 - 11:03 am
Pfizer
danuglipron
obesity
clinical trials
liver injury
This Pharma Company Is Betting Big On A Chinese Ozempic Rival
Forbes
Sun, 04/13/25 - 11:13 pm
Kailera Therapuetics
obesity
China
R&D
HHS leaves door open to future Medicare coverage of obesity drugs
BioSpace
Tue, 04/8/25 - 11:54 am
HHS
Medicare
obesity
Eli Lilly
Novo Nordisk
Rhythm Drug Leads to Reduced BMI in Rare Obesity Indication
BioSpace
Mon, 04/7/25 - 11:16 am
Rhythm Pharmaceuticals
Imcivree
obesity
clinical trials
hypothalamic obesity
Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
CNBC
Sun, 04/6/25 - 11:40 pm
Donald Trump
Medicare
obesity
GLP-1 agonist
Eli Lilly
Novo Nordisk
Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide
Fierce Biotech
Fri, 03/28/25 - 11:24 am
Lexicon Pharmaceuticals
Novo Nordisk
obesity
semaglutide
Ascletis slashes funding for former core programs in pivot to obesity
Fierce Biotech
Wed, 03/26/25 - 10:39 am
Ascletis Pharma
obesity
metabolic diseases
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Fierce Biotech
Mon, 03/24/25 - 11:20 am
Novo Nordisk
obesity
United Laboratories
triple G agonists
UBT251
Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset
Fierce Biotech
Mon, 03/24/25 - 11:08 am
Mira Pharmaceuticals
M&A
Skny Pharmaceuticals
obesity
smoking cessation
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy
Fierce Pharma
Mon, 03/24/25 - 11:05 am
Novo Nordisk
Wegovy
NovoCare Pharmacy
obesity
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Mon, 03/24/25 - 10:58 am
Eli Lilly
Novo Nordisk
obesity
DTC
Mounjaro
Wegovy
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Yahoo/Reuters
Fri, 03/21/25 - 11:42 am
gene therapy
rare disease
cancer
obesity
weight loss
drug development
OPKO and Entera Bio partner on oral obesity treatment
Investing.com
Mon, 03/17/25 - 11:22 am
OPKO Health
Entera Bio
obesity
Altimmune to test obesity drug for alcohol use disorder and related health conditions
MSN/Reuters
Fri, 03/14/25 - 11:40 am
Altimmune
obesity
pemvidutide
alcohol use disorder
MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup
BioPharma Dive
Thu, 03/13/25 - 11:25 pm
MeiraGTx
Hologen
obesity
gene therapy
Parkinson's Disease
Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-life
Clinical Trials Arena
Wed, 03/12/25 - 11:18 pm
Asceletis
obesity
ASC47
Harbour BioMed launches new obesity biotech on mission to preserve muscle mass
Fierce Biotech
Wed, 03/12/25 - 11:21 am
Harbour BioMed
obesity
bispecific antibodies
Élancé Therapeutics

Pages